STROMAL CELLS MAINTAIN THE RADIOPROTECTIVE CAPACITY OF CFU-S DURING RETROVIRAL INFECTION

Citation
F. Goncalves et al., STROMAL CELLS MAINTAIN THE RADIOPROTECTIVE CAPACITY OF CFU-S DURING RETROVIRAL INFECTION, Gene therapy, 3(9), 1996, pp. 761-768
Citations number
31
Categorie Soggetti
Pharmacology & Pharmacy","Genetics & Heredity",Biology
Journal title
ISSN journal
09697128
Volume
3
Issue
9
Year of publication
1996
Pages
761 - 768
Database
ISI
SICI code
0969-7128(1996)3:9<761:SCMTRC>2.0.ZU;2-9
Abstract
Retroviral vectors provide an efficient means to introduce genes into hematopoietic stem cells. In order to develop retroviral infection pro tocols which preserve the radioprotective capacity of CFU-S, we design ed a clonal hematopoietic reconstitution assay. In this assay, single CFU-S-derived colonies from bone marrow cells of 5-FU-treated mice wer e tested for their capacity to prevent radiation-induced mortality. Th ree parameters which may modify stem cell potential were tested in inf ection protocols using a retroviral vector containing the gene for neo mycin resistance: (1) the partition of stem cells between the adherent and nonadherent fraction; (2) the replacement of the packaging cell l ine by a 'competent' stromal cell line; and (3) the effects of G418 se lection. All CFU-S having radioprotective capacity were found in the a dherent fraction when the packaging cell line or the stromal cell line (MS-5) chosen for its capacity to maintain long-term bone marrow cult ure were used-during the co-culture. The neo resistance gene was trans duced into CFU-S with the same efficiency using co-culture with the pa ckaging cell line or co-culture with the MS-5 cell line plus viral sup ernatant. However, in the presence of MS-5, a much higher proportion o f CFU-S (70% versus 30%) had radioprotective properties, suggesting an important role for the stromal cells in the maintenance of hematopoie tic reconstituting ability. Finally, G418 selection, even for a limite d period (24 h), significantly decreased the radioprotective capacitie s of CFU-S (56% versus 18%). Subsequently, hematopoietic reconstitutio n 1 by single CFU-S was quantified in recipient mice. The progeny of C FU-S were found at a significant level in the blood, spleen and bone m arrow in 38% and 15% of mice, 1 and 3 months after transplantation res pectively. These results demonstrate that we have substantially improv ed the infection protocol. Under these conditions of infection, if is possible to conserve CFU-S properties and to transduce a gene into a s tem cell with short-term hematopoietic reconstitution potential.